Clarithromycin as Immunomodulator for the Management of Sepsis

NCT01223690 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Severe Sepsis
Septic Shock

Interventions

DRUG: Clarithromycin
DRUG: Dextrose 5%

Sponsor

University of Athens